-
1 Comment
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 82.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd's total revenue sank by 2.6% to $4B since the same quarter in the previous year.
Its net income has dropped by 76.7% to $33M since the same quarter in the previous year.
Finally, its free cash flow grew by 101.4% to $456M since the same quarter in the previous year.
Based on the above factors, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | SHE |
CurrencyCode | CNY |
ISIN | CNE0000011K8 |
PE Ratio | 16.45 |
---|---|
Target Price | 54.4522 |
Dividend Yield | 5.8% |
Beta | 0.29 |
Market Cap | 54B |
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injections; formula granules; and anti-infective drugs. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. operate as a subsidiary of China Resources Pharmaceutical Group Limited
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000999.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025